COVID-19 and anti-N-methyl-d-aspartate receptor (anti-NMDAR) encephalitis: Are we facing an increase in the prevalence of autoimmune encephalitis?

J Med Virol. 2021 Apr;93(4):1913-1914. doi: 10.1002/jmv.26745. Epub 2020 Dec 29.

Authors

Atefeh Zandifar^{1

2}, Rahim Badrfam³

Affiliations

¹ Cardiovascular Research Center, Shahid Rajaei Educational & Medical Center, Alborz University of Medical Sciences, Karaj, Iran.
² Social Determinants of Health Research Center, Alborz University of Medical Sciences, Karaj, Iran.
³ Department of Psychiatry, Roozbeh Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.

PMID: 33336825
DOI: 10.1002/jmv.26745

No abstract available

Keywords: COVID-19; anti-N-methyl-d-aspartate receptor (anti-NMDAR); autoimmune encephalitis.

Publication types

Case Reports
Letter

MeSH terms

Anti-N-Methyl-D-Aspartate Receptor Encephalitis / epidemiology
Anti-N-Methyl-D-Aspartate Receptor Encephalitis / etiology*
COVID-19 / complications*
Humans
Infant
Middle Aged
Prevalence
United Kingdom / epidemiology
Young Adult